BNET Industries
Invitrogen Corp. is in the Pharma Industry
Latest News and Analysis
Invitrogen to Present at the UBS 2007 Global Life Science Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today that Greg Lucier, Chairman and Chief Executive Officer, will present at the UBS 2007 Global Life Science Conference being held at the Grand Hyatt, Park Avenue at Grand Central Terminal...
Invitrogen to Present at 2006 UBS Global Life Science Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) announced it will present at the 2006 UBS Global Life Science Conference on Tuesday, September 26, 2006 at 3:00 p.m. Eastern Time at the Grand Hyatt Hotel in New York City. To hear a live webcast of the presentation, visit the investor relations page...
Invitrogen to Present at UBS Global Life Sciences Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN), announced today that Gregory T. Lucier, Invitrogen's Chairman and CEO, will present at the UBS Global Life Sciences Conference in New York City, New York today, September 27 at 11:00 a.m. Eastern Time. Mr. Lucier's presentation will be webcast and available for viewing live...
Invitrogen To Present at the UBS Global Life Sciences Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) announced that Gregory T. Lucier, Chairman and Chief Executive Officer, will be speaking at the UBS Global Life Sciences Conference on Monday, September 27, 2004 at 8:30 a.m. ET. The conference is being held at The Grand Hyatt in New York, N.Y.
Additional Resources
Invitrogen & Applied Biosystems Merge to Form Life Technologies; Fitch Rtd 'BBB-'
CHICAGO -- On Nov. 21, 2008, Invitrogen Corp. and Applied Biosystems Inc. completed their previously announced merger to form a new company named Life Technologies Corp. In a press release dated Aug. 4, 2008, Fitch assigned the following ratings to the merged entity: --Issuer Default Rating IDR 'BBB-';...
Invitrogen and Applied Biosystems Complete Merger
Combined Company, Called Life Technologies Corporation, is a Global Leader in Biotechnology Reagents and Systems Company to Begin Trading Under Ticker Symbol LIFE CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced the successful completion of their merger transaction. The new company...
Invitrogen and Applied Biosystems Announce Preliminary Results of Election Regarding Merger Consideration
CARLSBAD, Calif. & NORWALK, Conn. -- Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced the preliminary results of elections made by Applied Biosystems stockholders regarding their preferences as to the form of merger consideration they will receive in the pending acquisition of Applied Biosystems by Invitrogen. The election...
Invitrogen Launches In Vivo RNAi Delivery Reagent
Products to Simplify and Enable Research on All Sequencing Platforms CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the introduction of its Invivofectamine[TM] delivery reagent which enables short interference ribonucleic acid siRNA experiments in vivo. ...
Technical Note: E-PAGE™ 48- and 96-Well Gels on the Odyssey® Infrared Imaging System
LINCOLN, Neb., Nov. 19 /PRNewswire/ -- LI-COR Biosciences has released a new Technical Note for using E-PAGE 48- and 96-well gels the Odyssey Infrared Imaging System. The E-PAGE 48- and 96-well electrophoresis systems (Invitrogen Corporation, Carlsbad, CA) provide a high-throughput SDS-PAGE method for processing protein samples. When...
Invitrogen, BayBio Sign Partnership Agreement
CARLSBAD, Calif. & SOUTH SAN FRANCISCO, Calif. -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today its partnership with BayBio, a leading voice for the life sciences industry in Northern California. "BayBio is a vital voice for California's life...
Invitrogen and Applied Biosystems Announce European Commission Merger Clearance
Closing Date of Merger Scheduled for November 21, 2008; Deadline for Merger Consideration Elections to be Close of Business on November 19, 2008 CARLSBAD, Calif. & NORWALK, Conn. -- Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced that they have received clearance from the European Commission...
Invitrogen Launches Microarray to Study Non-Coding RNA
Agilent Technologies to Manufacture Unique Array for Invitrogen CARLSBAD, Calif. & SANTA CLARA, Calif. -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the launch of the first high-density microarray for the profiling of non-coding RNAs. The NCode[TM] Human...
Invitrogen Provides Update on Merger with Applied Biosystems
Three Applied Biosystems Board Members Named to New Board New Name Chosen for Combined Company CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN) today announced progress against its integration plans regarding its pending merger with Applied Biosystems. The company announced that three members of the Applied...
Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: IVGN, DENN, POT, NOK, CP, MF
DALLAS, Oct. 30 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m Today's Trade Alerts include: Invitrogen Corp. , Denny's Corp. , Potash Corp. of Saskatchewan...
Applied Biosystems Stockholders Approve Merger with Invitrogen
NORWALK, Conn. -- Applied Biosystems Inc. (NYSE:ABI) today announced that its stockholders have voted to approve the company's proposed merger with Invitrogen Corporation (NASDAQ:IVGN) at a special meeting of stockholders held today. "We are pleased with the overwhelming support of this transaction by our stockholders," said Tony L....
Invitrogen Shareholders Approve Merger with Applied Biosystems
Company Provides Update on Merger CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ: IVGN) today announced that its shareholders have voted to approve the company's proposed merger with Applied Biosystems Inc. (NYSE: ABI) at a special meeting of shareholders held today. "We are pleased with the outcome of...
Opportunities for Life Science Suppliers Plentiful in Rapidly Growing miRNA Research Markets
MicroRNA miRNA Segment Leaders Invitrogen and Applied Biosystems Face Many Niche Competitors - Revealed in New miRNA Market Research Report from Percepta Associates CARLSBAD, Calif. -- Today Percepta Associates Inc. announced the release of MicroRNA Analysis in North America: A research market report for life science tool providers....
Invitrogen Announces Third Quarter 2008 Financial Results
Third quarter revenue of $362 million, 15 percent increase Third quarter GAAP EPS of $0.26 and non-GAAP EPS $0.69 Free cash flow $61 million for the quarter CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) today announced results for its third quarter ended September 30, 2008....
Applied Biosystems Adjourns Special Meeting of Stockholders Until October 28, 2008; Votes, Proxies and Merger Consideration Elections Already Submitted Will Remain Valid
Deadline for Cash, Stock, and Mixed Consideration Elections Expected to Be in November 2008 NORWALK, Conn. -- Consistent with its press release issued last week, Applied Biosystems Inc. (NYSE:ABI) adjourned Thursday's special meeting of stockholders relating to the pending merger with Invitrogen Corporation until 9:00 a.m. Eastern time...
Invitrogen and Applied Biosystems Amend Merger Agreement to Eliminate Tax Opinion Condition; Stockholder Meetings to Be Moved to October 28, 2008
CARLSBAD, Calif. & FOSTER CITY, Calif. -- Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced that they have amended their pending merger agreement to eliminate a condition to closing requiring that the parties receive certain opinions of their respective counsel as to the tax treatment of the transaction....
- Next »
- page 1 of 1
- « Previous
Sort byClose
View Related Content by Tag Close
Industry Transcripts by Seeking Alpha
-
Indevus Pharmaceuticals, Inc. F4Q08 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 25, 2008about IDEV
-
Noven Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about NOVN
-
XenoPort, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about XNPT
-
Repligen Corporation F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 24, 2008about RGEN
-
Omrix Biopharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about OMRI